Similar articles for PMID: 31512147

Year	Number of Results
1977	1
1979	1
2005	1
2006	3
2007	2
2008	3
2009	4
2010	4
2011	4
2012	6
2013	8
2014	14
2015	18
2016	10
2017	22
2018	17
2019	25
2020	22
2021	22
2022	22
2023	13
2024	0

1

Efficacy of cefoxitin versus carbapenem in febrile male urinary tract infections caused by extended spectrum beta-lactamase-producing Escherichia coli: a multicenter retrospective cohort study with propensity score analysis.

Senard O, Lafaurie M, Lesprit P, Nguyen Y, Lescure X, Therby A, Fihman V, Oubaya N, Lepeule R. Senard O, et al. Eur J Clin Microbiol Infect Dis. 2020 Jan;39(1):121-129. doi: 10.1007/s10096-019-03701-0. Epub 2019 Sep 11. Eur J Clin Microbiol Infect Dis. 2020. PMID: 31512147

2

Cefoxitin as an alternative to carbapenems in a murine model of urinary tract infection due to Escherichia coli harboring CTX-M-15-type extended-spectrum β-lactamase.

Lepeule R, Ruppé E, Le P, Massias L, Chau F, Nucci A, Lefort A, Fantin B. Lepeule R, et al. Antimicrob Agents Chemother. 2012 Mar;56(3):1376-81. doi: 10.1128/AAC.06233-11. Epub 2012 Jan 3. Antimicrob Agents Chemother. 2012. PMID: 22214774 Free PMC article.

3

Efficacy of non-carbapenem antibiotics for pediatric patients with first febrile urinary tract infection due to extended-spectrum beta-lactamase-producing Escherichia coli.

Abe Y, Inan-Erdogan I, Fukuchi K, Wakabayashi H, Ogawa Y, Hibino S, Sakurai S, Matsuhashi K, Watanabe Y, Hashimoto K, Ugajin K, Itabashi K. Abe Y, et al. J Infect Chemother. 2017 Aug;23(8):517-522. doi: 10.1016/j.jiac.2017.04.006. Epub 2017 May 18. J Infect Chemother. 2017. PMID: 28528936

4

Cefoxitin: An alternative to carbapenems in urinary tract infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae.

Mambie A, Vuotto F, Poitrenaud D, Weyrich P, Cannesson O, Dessein R, Faure K, Guery B, Galpérine T. Mambie A, et al. Med Mal Infect. 2016 Jun;46(4):215-9. doi: 10.1016/j.medmal.2016.04.008. Med Mal Infect. 2016. PMID: 27210283

5

Cefoxitin-based antibiotic therapy for extended-spectrum β-lactamase-producing Enterobacteriaceae prostatitis: a prospective pilot study.

Demonchy E, Courjon J, Ughetto E, Durand M, Risso K, Garraffo R, Roger PM. Demonchy E, et al. Int J Antimicrob Agents. 2018 Jun;51(6):836-841. doi: 10.1016/j.ijantimicag.2018.01.008. Epub 2018 May 9. Int J Antimicrob Agents. 2018. PMID: 29378342

6

Impact of reflex fosfomycin susceptibility testing on the utilization of carbapenems for definitive extended-spectrum β-lactamase Escherichia coli urinary tract infection treatment.

Deemer K, Grey J, Fronczek C, Marr K. Deemer K, et al. Am J Health Syst Pharm. 2020 Nov 16;77(Supplement_4):S105-S110. doi: 10.1093/ajhp/zxaa174. Am J Health Syst Pharm. 2020. PMID: 32840305

7

The efficacy of non-carbapenem antibiotics for the treatment of community-onset acute pyelonephritis due to extended-spectrum β-lactamase-producing Escherichia coli.

Park SH, Choi SM, Chang YK, Lee DG, Cho SY, Lee HJ, Choi JH, Yoo JH. Park SH, et al. J Antimicrob Chemother. 2014 Oct;69(10):2848-56. doi: 10.1093/jac/dku215. Epub 2014 Jun 13. J Antimicrob Chemother. 2014. PMID: 24928854

8

Aminoglycoside therapy for childhood urinary tract infection due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.

Han SB, Lee SC, Lee SY, Jeong DC, Kang JH. Han SB, et al. BMC Infect Dis. 2015 Oct 13;15:414. doi: 10.1186/s12879-015-1153-z. BMC Infect Dis. 2015. PMID: 26464143 Free PMC article.

9

Carbapenem versus fosfomycin tromethanol in the treatment of extended-spectrum beta-lactamase-producing Escherichia coli-related complicated lower urinary tract infection.

Senol S, Tasbakan M, Pullukcu H, Sipahi OR, Sipahi H, Yamazhan T, Arda B, Ulusoy S. Senol S, et al. J Chemother. 2010 Oct;22(5):355-7. doi: 10.1179/joc.2010.22.5.355. J Chemother. 2010. PMID: 21123160

10

Randomized controlled trial of piperacillin-tazobactam, cefepime and ertapenem for the treatment of urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli.

Seo YB, Lee J, Kim YK, Lee SS, Lee JA, Kim HY, Uh Y, Kim HS, Song W. Seo YB, et al. BMC Infect Dis. 2017 Jun 7;17(1):404. doi: 10.1186/s12879-017-2502-x. BMC Infect Dis. 2017. PMID: 28592240 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

186 results

Results by year